Superficial bladder cancer: part 1. Update on etiology, classification and natural history (Q36689131)

15 August 2017

1 reference

title

Superficial bladder cancer: part 1. Update on etiology, classification and natural history (English)

1 reference

15 August 2017

1 reference

David Y Josephson

1

1 reference

15 August 2017

Erik Pasin

series ordinal

2

1 reference

15 August 2017

John P Stein

series ordinal

3

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

1723-1734

1 reference

15 August 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Interindividual variation in carcinogen metabolism and bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Concepts in causality: chemically induced human urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Arylamine exposures and bladder cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Occupational exposure and urological cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Risk of urinary tract cancers following kidney or ureter stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Detection of the c-myc gene product in urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Superficial bladder tumor. Aspects of clinical progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

The actual incidence of bladder perforation following transurethral bladder surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Risk factors for upper tract recurrence in patients undergoing long-term surveillance for stage ta bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Fluorescence detection of bladder cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

The 2004 WHO classification of bladder tumors: a summary and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Urothelial papilloma of the bladder: a review of 34 de novo cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Recurrence and progression in low grade papillary urothelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.12.1723

10.1586/14737140.6.12.1723

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference